Article
In vitro antifungal susceptibility of Cryptococcus gattii
Registro en:
TRILLES, Luciana et al. In vitro antifungal susceptibility of Cryptococcus gattii. Journal of Clinical Microbiology, v. 42, n. 10, p. 4815-4817, Oct. 2004.
0095-1137
10.1128/JCM.42.10.4815–4817.2004
1098-660X
Autor
Trilles, L.
Torres, B. F.
Lazéra, M. S.
Wanke, B.
Guarro, J.
Resumen
We have determined the in vitro susceptibilities of 57 strains of Cryptococcus gattii to nine antifungal agents
and have compared the MICs for these strains with those for C. neoformans. MICs were determined by a
microdilution reference method. Albaconazole and ravuconazole (MICs of 0.04 and 0.05 µg/ml, respectively)
showed the best activities. Micafungin showed no activity (MIC of >128 µg/ml). In general, C. gattii was less
susceptible than C. neoformans to all drugs tested, with the exception of amphotericin B and flucytosine. 2019-11-20